XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Income    
Revenue $ 4,993  
Cost of revenue (4,993)  
Operating Expenses:    
Research and development 4,431,601 $ 2,521,950
General and administrative 3,835,223 2,936,886
Reacquisition of license rights 2,000,000  
Total Operating Expenses 10,266,824 5,458,836
Loss From Operations (10,266,824) (5,458,836)
Other Income (Expense):    
Other (expense) income , net (97,558) 70,993
Interest expense (678,658) (454,003)
Interest income 120,939 102,480
Total Other Expense (655,277) (280,530)
Net Loss $ (10,922,101) $ (5,739,366)
Net Loss Per Share    
Net Loss Per Share - Basic $ (0.23) $ (0.15)
Net Loss Per Share - Diluted $ (0.23) $ (0.15)
Weighted Average Number of Common Shares Outstanding    
Shares Outstanding - Basic 46,606,790 37,410,587
Shares Outstanding - Diluted 46,606,790 37,410,587